NCT03712865View on ClinicalTrials.gov

Thirty Day Heart Monitoring for Detection of Atrial Fibrillation Among Cryptogenic Stroke Patients

CompletedOBSERVATIONAL

Enrollment

232

Participants

Timeline

Start Date

November 19, 2015

Primary Completion Date

March 3, 2022

Study Completion Date

March 3, 2022

Conditions

Embolic Stroke of Undetermined Source

Trial Locations (1)

V5Z 1M9

Vancouver Stroke Program, Vancouver

Sponsors

Collaborators (1)

Boehringer Ingelheim

All Listed Sponsors

collaborator

Boehringer Ingelheim

INDUSTRY

lead

University of British Columbia

OTHER

NCT03712865 - Thirty Day Heart Monitoring for Detection of Atrial Fibrillation Among Cryptogenic Stroke Patients | Biotech Hunter | Biotech Hunter